Lamie的个人主页 - 老虎社区

Lamie

暂无个人介绍

IP属地：未知

3关注

1粉丝

0主题

0勋章

2021-12-23

$THE HOUR GLASS LIMITED(AGS.SI)$more share buyback yesterday...owner will push it up again

2021-12-22

$VENTURE CORPORATION LIMITED(V03.SI)$just keep it for dividends, it is cash rich.

2021-12-22

$THE HOUR GLASS LIMITED(AGS.SI)$lets test new high towards new year

2021-12-02

Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.

Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>

2021-11-19

Nice

Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>

2021-11-18

Lets rock tonight

抱歉，原内容已删除

2021-08-20

Wtf

Snowflake Drops Most in Five Months Amid Cautious Analyst Report By Esha Dey<blockquote>Esha Dey的分析师报告谨慎，Snowflake跌幅为五个月来最大</blockquote>

2021-07-15

Norm is earnings out SP drops but not sure about TSM

TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>芯片需求强劲台积电第二季度利润增长11%</blockquote>

2021-07-13

Good for financials

Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6月份消费者价格指数上涨5.4%，预期为5%</blockquote>

2021-07-05

Let them short

Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>

2021-06-17

Go go go

Vaccine sector stocks gained in pre-market trading.<blockquote>疫苗板块股票在盘前交易中上涨。</blockquote>

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3565499732569971","uuid":"3565499732569971","gmtCreate":1612080367627,"gmtModify":1612080367627,"name":"Lamie","pinyin":"lamie","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":3,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.79%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.29","exceedPercentage":"93.17%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691485880,"gmtCreate":1640228049071,"gmtModify":1640228049141,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>more share buyback yesterday...owner will push it up again","listText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>more share buyback yesterday...owner will push it up again","text":"$THE HOUR GLASS LIMITED(AGS.SI)$more share buyback yesterday...owner will push it up again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/691485880","isVote":1,"tweetType":1,"viewCount":2253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691834800,"gmtCreate":1640163150399,"gmtModify":1640163150399,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/V03.SI\">$VENTURE CORPORATION LIMITED(V03.SI)$</a>just keep it for dividends, it is cash rich.","listText":"<a href=\"https://laohu8.com/S/V03.SI\">$VENTURE CORPORATION LIMITED(V03.SI)$</a>just keep it for dividends, it is cash rich.","text":"$VENTURE CORPORATION LIMITED(V03.SI)$just keep it for dividends, it is cash rich.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691834800","isVote":1,"tweetType":1,"viewCount":2761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691152769,"gmtCreate":1640153987583,"gmtModify":1640153987583,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>lets test new high towards new year","listText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>lets test new high towards new year","text":"$THE HOUR GLASS LIMITED(AGS.SI)$lets test new high towards new year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691152769","isVote":1,"tweetType":1,"viewCount":2201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603247312,"gmtCreate":1638418786833,"gmtModify":1638419068422,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","listText":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","text":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603247312","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohu8.com/m/news/1119742422?lang=zh_CN&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-01 22:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876590686,"gmtCreate":1637328918193,"gmtModify":1637328919371,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876590686","repostId":"1144455380","repostType":4,"repost":{"id":"1144455380","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637328728,"share":"https://www.laohu8.com/m/news/1144455380?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:32","market":"us","language":"en","title":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144455380","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S","content":"<p>Pfizer and BioNTech SE stocks climbed about 2%&nbsp;in premarket trading&nbsp;after&nbsp;they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和BioNTech SE的股价在盘前交易中上涨约2%，此前它们获得了美国FDA扩大的加强剂紧急使用授权，将18岁及以上的个人纳入其中。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc.&nbsp;and BioNTech SE&nbsp;today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），以包括18岁及以上的个人。加强剂量将在主要系列完成后至少六个月施用，并且剂量强度与主要系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>董事长Albert Bourla表示：“随着我们抗击COVID-19的斗争接近两年，我们达到了另一个重要里程碑，扩大了对18岁及以上人群的COVID-19疫苗加强剂量的授权。”辉瑞公司主席兼首席执行官。“有了加强剂，更多的成年人现在将有机会帮助保持针对这种疾病的高水平保护。我们感谢FDA的严格审查，以及今天采取的行动，我们希望这将有助于加速我们走出这场大流行。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>BioNTech首席执行官兼联合创始人Ugur Sahin医学博士表示：“今天FDA的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后产生了强大的免疫反应，甚至超过了高效的两剂主要计划完成后的免疫反应。”“这些数据表明，我们疫苗的加强剂量有可能对包括Delta在内的经过测试的变种保持高水平的保护。”</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10月，两家公司宣布了该试验的积极顶线结果，显示与未接受过辉瑞-BioNTech初级两剂系列的个人相比，对之前接受过辉瑞-BioNTech初级两剂系列的个人进行的加强剂量显示出95%的相对疫苗功效。到目前为止，这是第一个也是唯一一个从任何随机、对照的新冠肺炎疫苗加强试验中披露的疗效数据。不良事件概况与疫苗的其他临床安全性数据基本一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在完成初级系列后紧急使用，用于65岁及以上的个人、18至64岁的严重新冠肺炎高风险个人、18至64岁经常在机构或职业中暴露于新型冠状病毒的个人，以及已完成不同授权新冠肺炎疫苗初级疫苗接种的合格个人。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和BioNTech根据与美国政府现有的供应协议继续供应疫苗，包括足够的疫苗剂量，该协议将持续至2022年4月。这些公司预计今天的消息不会影响与世界各地政府和国际卫生组织的现有供应协议。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and BioNTech SE stocks climbed about 2%&nbsp;in premarket trading&nbsp;after&nbsp;they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和BioNTech SE的股价在盘前交易中上涨约2%，此前它们获得了美国FDA扩大的加强剂紧急使用授权，将18岁及以上的个人纳入其中。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc.&nbsp;and BioNTech SE&nbsp;today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），以包括18岁及以上的个人。加强剂量将在主要系列完成后至少六个月施用，并且剂量强度与主要系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>董事长Albert Bourla表示：“随着我们抗击COVID-19的斗争接近两年，我们达到了另一个重要里程碑，扩大了对18岁及以上人群的COVID-19疫苗加强剂量的授权。”辉瑞公司主席兼首席执行官。“有了加强剂，更多的成年人现在将有机会帮助保持针对这种疾病的高水平保护。我们感谢FDA的严格审查，以及今天采取的行动，我们希望这将有助于加速我们走出这场大流行。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>BioNTech首席执行官兼联合创始人Ugur Sahin医学博士表示：“今天FDA的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后产生了强大的免疫反应，甚至超过了高效的两剂主要计划完成后的免疫反应。”“这些数据表明，我们疫苗的加强剂量有可能对包括Delta在内的经过测试的变种保持高水平的保护。”</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10月，两家公司宣布了该试验的积极顶线结果，显示与未接受过辉瑞-BioNTech初级两剂系列的个人相比，对之前接受过辉瑞-BioNTech初级两剂系列的个人进行的加强剂量显示出95%的相对疫苗功效。到目前为止，这是第一个也是唯一一个从任何随机、对照的新冠肺炎疫苗加强试验中披露的疗效数据。不良事件概况与疫苗的其他临床安全性数据基本一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在完成初级系列后紧急使用，用于65岁及以上的个人、18至64岁的严重新冠肺炎高风险个人、18至64岁经常在机构或职业中暴露于新型冠状病毒的个人，以及已完成不同授权新冠肺炎疫苗初级疫苗接种的合格个人。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和BioNTech根据与美国政府现有的供应协议继续供应疫苗，包括足够的疫苗剂量，该协议将持续至2022年4月。这些公司预计今天的消息不会影响与世界各地政府和国际卫生组织的现有供应协议。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144455380","content_text":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.\n\nPfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\n“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”\nIn October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.\nA booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.\nPfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878597951,"gmtCreate":1637204011642,"gmtModify":1637204011642,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Lets rock tonight","listText":"Lets rock tonight","text":"Lets rock tonight","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878597951","repostId":"2184885073","repostType":2,"isVote":1,"tweetType":1,"viewCount":2227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":836147492,"gmtCreate":1629467393216,"gmtModify":1633684639262,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Wtf","listText":"Wtf","text":"Wtf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/836147492","repostId":"1181270196","repostType":4,"repost":{"id":"1181270196","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629466972,"share":"https://www.laohu8.com/m/news/1181270196?lang=zh_CN&edition=full","pubTime":"2021-08-20 21:42","market":"us","language":"en","title":"Snowflake Drops Most in Five Months Amid Cautious Analyst Report   By Esha Dey<blockquote>Esha Dey的分析师报告谨慎，Snowflake跌幅为五个月来最大</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181270196","media":"Tiger Newspress","summary":"(Update: August 20, 2021 at 10:37 a.m. ET)\n(Aug 20) Snowflake shares drop as much as 11% on Friday, ","content":"<p><i><b>(Update: August 20, 2021 at 10:37 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间2021年8月20日上午10:37）</b></i></blockquote></p><p> (Aug 20)&nbsp;Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.</p><p><blockquote>（8月20日）Snowflake股价周五下跌11%，创下3月份以来最大盘中跌幅，此前Cleveland Research Graphic Dashboard报告称，该公司的签约增长较第一季度放缓，而消费增长可能与第一季度的水平相似。</blockquote></p><p> The report also said that the company’s partners were seeing sales cycles elongate on increased competition&nbsp;from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.</p><p><blockquote>该报告还称，由于来自超大规模企业的竞争加剧，该公司的合作伙伴看到销售周期延长，特别是谷歌的BigQuery Cleveland没有正式覆盖SNOW，也没有投资意见。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/091af68dd7c59cce7e1b1f053df2d729\" tg-width=\"1572\" tg-height=\"718\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Drops Most in Five Months Amid Cautious Analyst Report   By Esha Dey<blockquote>Esha Dey的分析师报告谨慎，Snowflake跌幅为五个月来最大</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Drops Most in Five Months Amid Cautious Analyst Report   By Esha Dey<blockquote>Esha Dey的分析师报告谨慎，Snowflake跌幅为五个月来最大</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-20 21:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><i><b>(Update: August 20, 2021 at 10:37 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间2021年8月20日上午10:37）</b></i></blockquote></p><p> (Aug 20)&nbsp;Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.</p><p><blockquote>（8月20日）Snowflake股价周五下跌11%，创下3月份以来最大盘中跌幅，此前Cleveland Research Graphic Dashboard报告称，该公司的签约增长较第一季度放缓，而消费增长可能与第一季度的水平相似。</blockquote></p><p> The report also said that the company’s partners were seeing sales cycles elongate on increased competition&nbsp;from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.</p><p><blockquote>该报告还称，由于来自超大规模企业的竞争加剧，该公司的合作伙伴看到销售周期延长，特别是谷歌的BigQuery Cleveland没有正式覆盖SNOW，也没有投资意见。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/091af68dd7c59cce7e1b1f053df2d729\" tg-width=\"1572\" tg-height=\"718\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181270196","content_text":"(Update: August 20, 2021 at 10:37 a.m. ET)\n(Aug 20) Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.\nThe report also said that the company’s partners were seeing sales cycles elongate on increased competition from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.","news_type":1,"symbols_score_info":{"SNOW":0.9}},"isVote":1,"tweetType":1,"viewCount":2284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147921660,"gmtCreate":1626328801950,"gmtModify":1633927802368,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Norm is earnings out SP drops but not sure about TSM","listText":"Norm is earnings out SP drops but not sure about TSM","text":"Norm is earnings out SP drops but not sure about TSM","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147921660","repostId":"1113252389","repostType":4,"repost":{"id":"1113252389","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626327337,"share":"https://www.laohu8.com/m/news/1113252389?lang=zh_CN&edition=full","pubTime":"2021-07-15 13:35","market":"us","language":"en","title":"TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>芯片需求强劲台积电第二季度利润增长11%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1113252389","media":"Tiger Newspress","summary":"Taiwan Semiconductor Manufacturing Co. reported an 11% increase in quarterly profit, underscoring ho","content":"<p><a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor Manufacturing</a> Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.</p><p><blockquote><a href=\"https://laohu8.com/S/TSM\">台积电</a>Co.报告季度利润增长11%，突显出该公司如何从全球芯片短缺中受益，这推动了汽车和其他行业的订单增加。</blockquote></p><p> Net income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.</p><p><blockquote>截至6月份的季度净利润升至新台币1,344亿元（合48亿美元），略低于分析师平均预期的1,361.5亿元。根据之前发布的月度销售数据，收入为新台币3,721.5亿元。</blockquote></p><p> While an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.</p><p><blockquote>尽管持续的半导体短缺阻碍了全球经济从Covid-19中复苏，但全球最大的合同芯片制造商台积电等供应商在竞相履行订单时也是受益者之一。这家台湾公司也可能从计划中获得提振<a href=\"https://laohu8.com/S/AAPL\">苹果</a>其最大客户Inc.将在今年下半年准备9000万部升级版iPhone。</blockquote></p><p> “As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” <a href=\"https://laohu8.com/S/C\">Citigroup</a> analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”</p><p><blockquote>“由于台积电可能会在未来几个季度继续以极高的利用率装载其产能，我们预计强劲的收入势头将持续到2021年底，”<a href=\"https://laohu8.com/S/C\">花旗集团</a>分析师Roland Shu上周在一份报告中写道。“强劲的需求但供应链产能增加有限，将继续使台积电能够最好地利用其产能，并进一步加强其定价能力。”</blockquote></p><p> In early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.</p><p><blockquote>7月初，戴姆勒股份公司和捷豹路虎警告称，持续的芯片短缺将进一步削减销量，后者表示第二季度的交付量将比最初想象的差50%。英国5月份经济增长放缓至0.8%，部分原因是半导体短缺导致运输设备产量下降16.4%。</blockquote></p><p> <a href=\"https://laohu8.com/S/UMC\">United Microelectronics</a> Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.</p><p><blockquote><a href=\"https://laohu8.com/S/UMC\">联合微电子</a>台积电规模较小的竞争对手Corp.上周表示，芯片需求可能会继续超过供应，直到2023年。</blockquote></p><p> In response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.</p><p><blockquote>为了应对汽车制造商的需求，台积电表示将增加对该行业的出货量。来自汽车客户的收入较第一季度增长了12%，而高性能计算也以类似的幅度攀升。智能手机客户的销售额是其收入的最大部分，在季节性放缓的第二季度下降了3%。</blockquote></p><p> Gross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., <a href=\"https://laohu8.com/S/AONE\">one</a> of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.</p><p><blockquote>毛利率为50%，低于分析师预测的约51%的平均水平。6月初，台湾中部一家工厂发生聚集性Covid-19感染，迫使金源电子股份有限公司(King Yuan Electronics Co.,<a href=\"https://laohu8.com/S/AONE\">一</a>全球领先的芯片测试服务提供商之一，暂时关闭运营。这导致全球许多人所依赖的台湾半导体供应链出现轻微中断。台积电周一表示，其三名员工被确认感染，但没有看到对运营有任何影响。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8972f21d044da7c44c189d05e553355d\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul>  <li>TSMC today announced consolidated <b>revenue of &nbsp;NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit)</b> for the second quarter ended June 30, 2021.</li>  <li>Year-over-year, second quarter <b>revenue increased 19.8% while net income and diluted EPS both increased 11.2%.</b> Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</li>  <li>In US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.</li>  <li><b>Gross margin for the quarter was 50.0%,</b> operating margin was 39.1%, and net profit margin was 36.1%.</li>  <li>In the second quarter, <b>shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%.</b> <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.</li> </ul> <img src=\"https://static.tigerbbs.com/3f1042154c2034c25d54d740e91d9a2e\" tg-width=\"658\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>台积电今日宣布合并<b>营收3721.5亿元，净收入1343.6亿元，每股摊薄收益5.18元（每ADR单位0.93美元）</b>截至2021年6月30日的第二季度。</li><li>第二季度同比<b>收入增长19.8%，净利润和摊薄后每股收益均增长11.2%。</b>与2021年第一季度相比，第二季度业绩收入增长2.7%，净利润下降3.8%。所有数字均根据TIFRS按综合基准编制。</li><li>以美元计算，第二季度营收为132.9亿美元，同比增长28.0%，环比增长2.9%。</li><li><b>本季度毛利率为50.0%，</b>营业利润率39.1%，净利润率36.1%。</li><li>二季度，<b>5纳米出货量占晶圆总收入的18%；7纳米占31%。</b><a href=\"https://laohu8.com/S/AEIS\">先进的</a>技术，定义为7纳米及更先进的技术，占晶圆总收入的49%。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>芯片需求强劲台积电第二季度利润增长11%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>芯片需求强劲台积电第二季度利润增长11%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-15 13:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor Manufacturing</a> Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.</p><p><blockquote><a href=\"https://laohu8.com/S/TSM\">台积电</a>Co.报告季度利润增长11%，突显出该公司如何从全球芯片短缺中受益，这推动了汽车和其他行业的订单增加。</blockquote></p><p> Net income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.</p><p><blockquote>截至6月份的季度净利润升至新台币1,344亿元（合48亿美元），略低于分析师平均预期的1,361.5亿元。根据之前发布的月度销售数据，收入为新台币3,721.5亿元。</blockquote></p><p> While an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.</p><p><blockquote>尽管持续的半导体短缺阻碍了全球经济从Covid-19中复苏，但全球最大的合同芯片制造商台积电等供应商在竞相履行订单时也是受益者之一。这家台湾公司也可能从计划中获得提振<a href=\"https://laohu8.com/S/AAPL\">苹果</a>其最大客户Inc.将在今年下半年准备9000万部升级版iPhone。</blockquote></p><p> “As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” <a href=\"https://laohu8.com/S/C\">Citigroup</a> analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”</p><p><blockquote>“由于台积电可能会在未来几个季度继续以极高的利用率装载其产能，我们预计强劲的收入势头将持续到2021年底，”<a href=\"https://laohu8.com/S/C\">花旗集团</a>分析师Roland Shu上周在一份报告中写道。“强劲的需求但供应链产能增加有限，将继续使台积电能够最好地利用其产能，并进一步加强其定价能力。”</blockquote></p><p> In early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.</p><p><blockquote>7月初，戴姆勒股份公司和捷豹路虎警告称，持续的芯片短缺将进一步削减销量，后者表示第二季度的交付量将比最初想象的差50%。英国5月份经济增长放缓至0.8%，部分原因是半导体短缺导致运输设备产量下降16.4%。</blockquote></p><p> <a href=\"https://laohu8.com/S/UMC\">United Microelectronics</a> Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.</p><p><blockquote><a href=\"https://laohu8.com/S/UMC\">联合微电子</a>台积电规模较小的竞争对手Corp.上周表示，芯片需求可能会继续超过供应，直到2023年。</blockquote></p><p> In response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.</p><p><blockquote>为了应对汽车制造商的需求，台积电表示将增加对该行业的出货量。来自汽车客户的收入较第一季度增长了12%，而高性能计算也以类似的幅度攀升。智能手机客户的销售额是其收入的最大部分，在季节性放缓的第二季度下降了3%。</blockquote></p><p> Gross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., <a href=\"https://laohu8.com/S/AONE\">one</a> of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.</p><p><blockquote>毛利率为50%，低于分析师预测的约51%的平均水平。6月初，台湾中部一家工厂发生聚集性Covid-19感染，迫使金源电子股份有限公司(King Yuan Electronics Co.,<a href=\"https://laohu8.com/S/AONE\">一</a>全球领先的芯片测试服务提供商之一，暂时关闭运营。这导致全球许多人所依赖的台湾半导体供应链出现轻微中断。台积电周一表示，其三名员工被确认感染，但没有看到对运营有任何影响。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8972f21d044da7c44c189d05e553355d\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul>  <li>TSMC today announced consolidated <b>revenue of &nbsp;NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit)</b> for the second quarter ended June 30, 2021.</li>  <li>Year-over-year, second quarter <b>revenue increased 19.8% while net income and diluted EPS both increased 11.2%.</b> Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</li>  <li>In US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.</li>  <li><b>Gross margin for the quarter was 50.0%,</b> operating margin was 39.1%, and net profit margin was 36.1%.</li>  <li>In the second quarter, <b>shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%.</b> <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.</li> </ul> <img src=\"https://static.tigerbbs.com/3f1042154c2034c25d54d740e91d9a2e\" tg-width=\"658\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>台积电今日宣布合并<b>营收3721.5亿元，净收入1343.6亿元，每股摊薄收益5.18元（每ADR单位0.93美元）</b>截至2021年6月30日的第二季度。</li><li>第二季度同比<b>收入增长19.8%，净利润和摊薄后每股收益均增长11.2%。</b>与2021年第一季度相比，第二季度业绩收入增长2.7%，净利润下降3.8%。所有数字均根据TIFRS按综合基准编制。</li><li>以美元计算，第二季度营收为132.9亿美元，同比增长28.0%，环比增长2.9%。</li><li><b>本季度毛利率为50.0%，</b>营业利润率39.1%，净利润率36.1%。</li><li>二季度，<b>5纳米出货量占晶圆总收入的18%；7纳米占31%。</b><a href=\"https://laohu8.com/S/AEIS\">先进的</a>技术，定义为7纳米及更先进的技术，占晶圆总收入的49%。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113252389","content_text":"Taiwan Semiconductor Manufacturing Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.\nNet income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.\nWhile an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by Apple Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.\n“As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” Citigroup analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”\nIn early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.\nUnited Microelectronics Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.\nIn response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.\nGross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., one of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.\n\n\nTSMC today announced consolidated revenue of  NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit) for the second quarter ended June 30, 2021.\nYear-over-year, second quarter revenue increased 19.8% while net income and diluted EPS both increased 11.2%. Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.\nIn US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.\nGross margin for the quarter was 50.0%, operating margin was 39.1%, and net profit margin was 36.1%.\nIn the second quarter, shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%. Advanced technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.","news_type":1,"symbols_score_info":{"TSM":0.9}},"isVote":1,"tweetType":1,"viewCount":1164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142755767,"gmtCreate":1626179721559,"gmtModify":1633929372871,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Good for financials","listText":"Good for financials","text":"Good for financials","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/142755767","repostId":"1162410134","repostType":4,"repost":{"id":"1162410134","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626179564,"share":"https://www.laohu8.com/m/news/1162410134?lang=zh_CN&edition=full","pubTime":"2021-07-13 20:32","market":"us","language":"en","title":"Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6月份消费者价格指数上涨5.4%，预期为5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1162410134","media":"Tiger Newspress","summary":"Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor D","content":"<p>Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.</p><p><blockquote>美国劳工部周二报告称，6月份通胀继续快速飙升，增速创近13年来最快。</blockquote></p><p> The consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.</p><p><blockquote>消费者价格指数同比上涨5.4%，为金融危机爆发前以来最大涨幅。道琼斯调查的经济学家此前预计将上涨5%。</blockquote></p><p> Stripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.</p><p><blockquote>剔除波动较大的食品和能源价格，核心CPI上涨4.5%，为1991年9月以来该指标的最大涨幅，远高于3.8%的预期。</blockquote></p><p> Inflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.</p><p><blockquote>由于多种因素，通胀一直在上升，包括供应链瓶颈、随着Covid-19大流行的缓解而异常高的需求，以及与危机最初几个月经济难以重新开放时的同比比较。</blockquote></p><p> Policymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.</p><p><blockquote>美联储和白宫的政策制定者预计当前的压力将开始缓解，尽管央行官员承认通胀比他们预期的更强劲，或许更持久。</blockquote></p><p> Much of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.</p><p><blockquote>大部分价格压力来自受政府关闭影响特别严重的行业——二手车价格、机票和运输成本等。</blockquote></p><p> However, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.</p><p><blockquote>然而，住房和住房价格继续攀升，加剧了人们对通胀可能会持续一段时间的看法。</blockquote></p><p> Consumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that</p><p><blockquote>纽约联储周一公布的一项调查显示，消费者预计未来12个月物价总体上涨4.8%，不过美国银行周二公布的另一项调查显示</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6月份消费者价格指数上涨5.4%，预期为5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsumer price index increases 5.4% in June vs. 5% estimate<blockquote>6月份消费者价格指数上涨5.4%，预期为5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-13 20:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.</p><p><blockquote>美国劳工部周二报告称，6月份通胀继续快速飙升，增速创近13年来最快。</blockquote></p><p> The consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.</p><p><blockquote>消费者价格指数同比上涨5.4%，为金融危机爆发前以来最大涨幅。道琼斯调查的经济学家此前预计将上涨5%。</blockquote></p><p> Stripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.</p><p><blockquote>剔除波动较大的食品和能源价格，核心CPI上涨4.5%，为1991年9月以来该指标的最大涨幅，远高于3.8%的预期。</blockquote></p><p> Inflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.</p><p><blockquote>由于多种因素，通胀一直在上升，包括供应链瓶颈、随着Covid-19大流行的缓解而异常高的需求，以及与危机最初几个月经济难以重新开放时的同比比较。</blockquote></p><p> Policymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.</p><p><blockquote>美联储和白宫的政策制定者预计当前的压力将开始缓解，尽管央行官员承认通胀比他们预期的更强劲，或许更持久。</blockquote></p><p> Much of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.</p><p><blockquote>大部分价格压力来自受政府关闭影响特别严重的行业——二手车价格、机票和运输成本等。</blockquote></p><p> However, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.</p><p><blockquote>然而，住房和住房价格继续攀升，加剧了人们对通胀可能会持续一段时间的看法。</blockquote></p><p> Consumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that</p><p><blockquote>纽约联储周一公布的一项调查显示，消费者预计未来12个月物价总体上涨4.8%，不过美国银行周二公布的另一项调查显示</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162410134","content_text":"Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.\nThe consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.\nStripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.\nInflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.\nPolicymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.\nMuch of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.\nHowever, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.\nConsumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1505,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154321641,"gmtCreate":1625482293784,"gmtModify":1633940318766,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Let them short","listText":"Let them short","text":"Let them short","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/154321641","repostId":"1199383023","repostType":4,"repost":{"id":"1199383023","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625234763,"share":"https://www.laohu8.com/m/news/1199383023?lang=zh_CN&edition=full","pubTime":"2021-07-02 22:06","market":"us","language":"en","title":"Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199383023","media":"Tiger Newspress","summary":"Iceberg Research, a short seller,said they're shorting AMC Entertainment.\nAMC stock tumbled 10% in F","content":"<p>Iceberg Research, a short seller,said&nbsp;they're shorting AMC Entertainment.</p><p><blockquote>卖空者Iceberg Research表示，他们正在做空AMC院线。</blockquote></p><p> AMC&nbsp;stock&nbsp;tumbled&nbsp;10%&nbsp;in Friday morning trading.</p><p><blockquote>AMC股价周五早盘下跌10%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fcd7b7275c61489d2f5ef4c91a74765\" tg-width=\"840\" tg-height=\"470\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-02 22:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Iceberg Research, a short seller,said&nbsp;they're shorting AMC Entertainment.</p><p><blockquote>卖空者Iceberg Research表示，他们正在做空AMC院线。</blockquote></p><p> AMC&nbsp;stock&nbsp;tumbled&nbsp;10%&nbsp;in Friday morning trading.</p><p><blockquote>AMC股价周五早盘下跌10%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fcd7b7275c61489d2f5ef4c91a74765\" tg-width=\"840\" tg-height=\"470\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199383023","content_text":"Iceberg Research, a short seller,said they're shorting AMC Entertainment.\nAMC stock tumbled 10% in Friday morning trading.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":161871614,"gmtCreate":1623919953238,"gmtModify":1634025869982,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/161871614","repostId":"1147243421","repostType":4,"repost":{"id":"1147243421","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623918768,"share":"https://www.laohu8.com/m/news/1147243421?lang=zh_CN&edition=full","pubTime":"2021-06-17 16:32","market":"us","language":"en","title":"Vaccine sector stocks gained in pre-market trading.<blockquote>疫苗板块股票在盘前交易中上涨。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147243421","media":"Tiger Newspress","summary":"Vaccine sector stocks gained in pre-market trading.\nNovavax,Moderna and BioNTech shares were up bewt","content":"<p>Vaccine&nbsp;sector&nbsp;stocks gained in pre-market&nbsp;trading.</p><p><blockquote>疫苗板块股票在盘前交易中上涨。</blockquote></p><p> Novavax,Moderna&nbsp;and&nbsp;BioNTech&nbsp;shares&nbsp;were&nbsp;up&nbsp;bewteen&nbsp;1%&nbsp;and&nbsp;5%.</p><p><blockquote>Novavax、Moderna和BioNTech股价上涨1%至5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bcf7ccd098da30e231e2f93a2600de4a\" tg-width=\"1291\" tg-height=\"641\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine sector stocks gained in pre-market trading.<blockquote>疫苗板块股票在盘前交易中上涨。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine sector stocks gained in pre-market trading.<blockquote>疫苗板块股票在盘前交易中上涨。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-06-17 16:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine&nbsp;sector&nbsp;stocks gained in pre-market&nbsp;trading.</p><p><blockquote>疫苗板块股票在盘前交易中上涨。</blockquote></p><p> Novavax,Moderna&nbsp;and&nbsp;BioNTech&nbsp;shares&nbsp;were&nbsp;up&nbsp;bewteen&nbsp;1%&nbsp;and&nbsp;5%.</p><p><blockquote>Novavax、Moderna和BioNTech股价上涨1%至5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bcf7ccd098da30e231e2f93a2600de4a\" tg-width=\"1291\" tg-height=\"641\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147243421","content_text":"Vaccine sector stocks gained in pre-market trading.\nNovavax,Moderna and BioNTech shares were up bewteen 1% and 5%.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":691485880,"gmtCreate":1640228049071,"gmtModify":1640228049141,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>more share buyback yesterday...owner will push it up again","listText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>more share buyback yesterday...owner will push it up again","text":"$THE HOUR GLASS LIMITED(AGS.SI)$more share buyback yesterday...owner will push it up again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/691485880","isVote":1,"tweetType":1,"viewCount":2253,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876590686,"gmtCreate":1637328918193,"gmtModify":1637328919371,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876590686","repostId":"1144455380","repostType":4,"repost":{"id":"1144455380","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637328728,"share":"https://www.laohu8.com/m/news/1144455380?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:32","market":"us","language":"en","title":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144455380","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S","content":"<p>Pfizer and BioNTech SE stocks climbed about 2%&nbsp;in premarket trading&nbsp;after&nbsp;they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和BioNTech SE的股价在盘前交易中上涨约2%，此前它们获得了美国FDA扩大的加强剂紧急使用授权，将18岁及以上的个人纳入其中。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc.&nbsp;and BioNTech SE&nbsp;today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），以包括18岁及以上的个人。加强剂量将在主要系列完成后至少六个月施用，并且剂量强度与主要系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>董事长Albert Bourla表示：“随着我们抗击COVID-19的斗争接近两年，我们达到了另一个重要里程碑，扩大了对18岁及以上人群的COVID-19疫苗加强剂量的授权。”辉瑞公司主席兼首席执行官。“有了加强剂，更多的成年人现在将有机会帮助保持针对这种疾病的高水平保护。我们感谢FDA的严格审查，以及今天采取的行动，我们希望这将有助于加速我们走出这场大流行。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>BioNTech首席执行官兼联合创始人Ugur Sahin医学博士表示：“今天FDA的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后产生了强大的免疫反应，甚至超过了高效的两剂主要计划完成后的免疫反应。”“这些数据表明，我们疫苗的加强剂量有可能对包括Delta在内的经过测试的变种保持高水平的保护。”</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10月，两家公司宣布了该试验的积极顶线结果，显示与未接受过辉瑞-BioNTech初级两剂系列的个人相比，对之前接受过辉瑞-BioNTech初级两剂系列的个人进行的加强剂量显示出95%的相对疫苗功效。到目前为止，这是第一个也是唯一一个从任何随机、对照的新冠肺炎疫苗加强试验中披露的疗效数据。不良事件概况与疫苗的其他临床安全性数据基本一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在完成初级系列后紧急使用，用于65岁及以上的个人、18至64岁的严重新冠肺炎高风险个人、18至64岁经常在机构或职业中暴露于新型冠状病毒的个人，以及已完成不同授权新冠肺炎疫苗初级疫苗接种的合格个人。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和BioNTech根据与美国政府现有的供应协议继续供应疫苗，包括足够的疫苗剂量，该协议将持续至2022年4月。这些公司预计今天的消息不会影响与世界各地政府和国际卫生组织的现有供应协议。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和BioNTech SE股价在盘前交易中上涨约2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and BioNTech SE stocks climbed about 2%&nbsp;in premarket trading&nbsp;after&nbsp;they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和BioNTech SE的股价在盘前交易中上涨约2%，此前它们获得了美国FDA扩大的加强剂紧急使用授权，将18岁及以上的个人纳入其中。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc.&nbsp;and BioNTech SE&nbsp;today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），以包括18岁及以上的个人。加强剂量将在主要系列完成后至少六个月施用，并且剂量强度与主要系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>董事长Albert Bourla表示：“随着我们抗击COVID-19的斗争接近两年，我们达到了另一个重要里程碑，扩大了对18岁及以上人群的COVID-19疫苗加强剂量的授权。”辉瑞公司主席兼首席执行官。“有了加强剂，更多的成年人现在将有机会帮助保持针对这种疾病的高水平保护。我们感谢FDA的严格审查，以及今天采取的行动，我们希望这将有助于加速我们走出这场大流行。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>BioNTech首席执行官兼联合创始人Ugur Sahin医学博士表示：“今天FDA的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后产生了强大的免疫反应，甚至超过了高效的两剂主要计划完成后的免疫反应。”“这些数据表明，我们疫苗的加强剂量有可能对包括Delta在内的经过测试的变种保持高水平的保护。”</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10月，两家公司宣布了该试验的积极顶线结果，显示与未接受过辉瑞-BioNTech初级两剂系列的个人相比，对之前接受过辉瑞-BioNTech初级两剂系列的个人进行的加强剂量显示出95%的相对疫苗功效。到目前为止，这是第一个也是唯一一个从任何随机、对照的新冠肺炎疫苗加强试验中披露的疗效数据。不良事件概况与疫苗的其他临床安全性数据基本一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在完成初级系列后紧急使用，用于65岁及以上的个人、18至64岁的严重新冠肺炎高风险个人、18至64岁经常在机构或职业中暴露于新型冠状病毒的个人，以及已完成不同授权新冠肺炎疫苗初级疫苗接种的合格个人。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和BioNTech根据与美国政府现有的供应协议继续供应疫苗，包括足够的疫苗剂量，该协议将持续至2022年4月。这些公司预计今天的消息不会影响与世界各地政府和国际卫生组织的现有供应协议。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144455380","content_text":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.\n\nPfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\n“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”\nIn October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.\nA booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.\nPfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":1747,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":142755767,"gmtCreate":1626179721559,"gmtModify":1633929372871,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Good for financials","listText":"Good for financials","text":"Good for financials","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/142755767","repostId":"1162410134","repostType":4,"repost":{"id":"1162410134","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626179564,"share":"https://www.laohu8.com/m/news/1162410134?lang=zh_CN&edition=full","pubTime":"2021-07-13 20:32","market":"us","language":"en","title":"Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6月份消费者价格指数上涨5.4%，预期为5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1162410134","media":"Tiger Newspress","summary":"Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor D","content":"<p>Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.</p><p><blockquote>美国劳工部周二报告称，6月份通胀继续快速飙升，增速创近13年来最快。</blockquote></p><p> The consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.</p><p><blockquote>消费者价格指数同比上涨5.4%，为金融危机爆发前以来最大涨幅。道琼斯调查的经济学家此前预计将上涨5%。</blockquote></p><p> Stripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.</p><p><blockquote>剔除波动较大的食品和能源价格，核心CPI上涨4.5%，为1991年9月以来该指标的最大涨幅，远高于3.8%的预期。</blockquote></p><p> Inflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.</p><p><blockquote>由于多种因素，通胀一直在上升，包括供应链瓶颈、随着Covid-19大流行的缓解而异常高的需求，以及与危机最初几个月经济难以重新开放时的同比比较。</blockquote></p><p> Policymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.</p><p><blockquote>美联储和白宫的政策制定者预计当前的压力将开始缓解，尽管央行官员承认通胀比他们预期的更强劲，或许更持久。</blockquote></p><p> Much of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.</p><p><blockquote>大部分价格压力来自受政府关闭影响特别严重的行业——二手车价格、机票和运输成本等。</blockquote></p><p> However, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.</p><p><blockquote>然而，住房和住房价格继续攀升，加剧了人们对通胀可能会持续一段时间的看法。</blockquote></p><p> Consumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that</p><p><blockquote>纽约联储周一公布的一项调查显示，消费者预计未来12个月物价总体上涨4.8%，不过美国银行周二公布的另一项调查显示</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6月份消费者价格指数上涨5.4%，预期为5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsumer price index increases 5.4% in June vs. 5% estimate<blockquote>6月份消费者价格指数上涨5.4%，预期为5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-13 20:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.</p><p><blockquote>美国劳工部周二报告称，6月份通胀继续快速飙升，增速创近13年来最快。</blockquote></p><p> The consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.</p><p><blockquote>消费者价格指数同比上涨5.4%，为金融危机爆发前以来最大涨幅。道琼斯调查的经济学家此前预计将上涨5%。</blockquote></p><p> Stripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.</p><p><blockquote>剔除波动较大的食品和能源价格，核心CPI上涨4.5%，为1991年9月以来该指标的最大涨幅，远高于3.8%的预期。</blockquote></p><p> Inflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.</p><p><blockquote>由于多种因素，通胀一直在上升，包括供应链瓶颈、随着Covid-19大流行的缓解而异常高的需求，以及与危机最初几个月经济难以重新开放时的同比比较。</blockquote></p><p> Policymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.</p><p><blockquote>美联储和白宫的政策制定者预计当前的压力将开始缓解，尽管央行官员承认通胀比他们预期的更强劲，或许更持久。</blockquote></p><p> Much of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.</p><p><blockquote>大部分价格压力来自受政府关闭影响特别严重的行业——二手车价格、机票和运输成本等。</blockquote></p><p> However, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.</p><p><blockquote>然而，住房和住房价格继续攀升，加剧了人们对通胀可能会持续一段时间的看法。</blockquote></p><p> Consumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that</p><p><blockquote>纽约联储周一公布的一项调查显示，消费者预计未来12个月物价总体上涨4.8%，不过美国银行周二公布的另一项调查显示</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162410134","content_text":"Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.\nThe consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.\nStripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.\nInflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.\nPolicymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.\nMuch of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.\nHowever, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.\nConsumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":1505,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":878597951,"gmtCreate":1637204011642,"gmtModify":1637204011642,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Lets rock tonight","listText":"Lets rock tonight","text":"Lets rock tonight","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878597951","repostId":"2184885073","repostType":2,"isVote":1,"tweetType":1,"viewCount":2227,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691152769,"gmtCreate":1640153987583,"gmtModify":1640153987583,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>lets test new high towards new year","listText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>lets test new high towards new year","text":"$THE HOUR GLASS LIMITED(AGS.SI)$lets test new high towards new year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691152769","isVote":1,"tweetType":1,"viewCount":2201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":836147492,"gmtCreate":1629467393216,"gmtModify":1633684639262,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Wtf","listText":"Wtf","text":"Wtf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/836147492","repostId":"1181270196","repostType":4,"repost":{"id":"1181270196","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629466972,"share":"https://www.laohu8.com/m/news/1181270196?lang=zh_CN&edition=full","pubTime":"2021-08-20 21:42","market":"us","language":"en","title":"Snowflake Drops Most in Five Months Amid Cautious Analyst Report   By Esha Dey<blockquote>Esha Dey的分析师报告谨慎，Snowflake跌幅为五个月来最大</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181270196","media":"Tiger Newspress","summary":"(Update: August 20, 2021 at 10:37 a.m. ET)\n(Aug 20) Snowflake shares drop as much as 11% on Friday, ","content":"<p><i><b>(Update: August 20, 2021 at 10:37 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间2021年8月20日上午10:37）</b></i></blockquote></p><p> (Aug 20)&nbsp;Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.</p><p><blockquote>（8月20日）Snowflake股价周五下跌11%，创下3月份以来最大盘中跌幅，此前Cleveland Research Graphic Dashboard报告称，该公司的签约增长较第一季度放缓，而消费增长可能与第一季度的水平相似。</blockquote></p><p> The report also said that the company’s partners were seeing sales cycles elongate on increased competition&nbsp;from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.</p><p><blockquote>该报告还称，由于来自超大规模企业的竞争加剧，该公司的合作伙伴看到销售周期延长，特别是谷歌的BigQuery Cleveland没有正式覆盖SNOW，也没有投资意见。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/091af68dd7c59cce7e1b1f053df2d729\" tg-width=\"1572\" tg-height=\"718\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Drops Most in Five Months Amid Cautious Analyst Report   By Esha Dey<blockquote>Esha Dey的分析师报告谨慎，Snowflake跌幅为五个月来最大</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Drops Most in Five Months Amid Cautious Analyst Report   By Esha Dey<blockquote>Esha Dey的分析师报告谨慎，Snowflake跌幅为五个月来最大</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-20 21:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><i><b>(Update: August 20, 2021 at 10:37 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间2021年8月20日上午10:37）</b></i></blockquote></p><p> (Aug 20)&nbsp;Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.</p><p><blockquote>（8月20日）Snowflake股价周五下跌11%，创下3月份以来最大盘中跌幅，此前Cleveland Research Graphic Dashboard报告称，该公司的签约增长较第一季度放缓，而消费增长可能与第一季度的水平相似。</blockquote></p><p> The report also said that the company’s partners were seeing sales cycles elongate on increased competition&nbsp;from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.</p><p><blockquote>该报告还称，由于来自超大规模企业的竞争加剧，该公司的合作伙伴看到销售周期延长，特别是谷歌的BigQuery Cleveland没有正式覆盖SNOW，也没有投资意见。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/091af68dd7c59cce7e1b1f053df2d729\" tg-width=\"1572\" tg-height=\"718\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181270196","content_text":"(Update: August 20, 2021 at 10:37 a.m. ET)\n(Aug 20) Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.\nThe report also said that the company’s partners were seeing sales cycles elongate on increased competition from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.","news_type":1,"symbols_score_info":{"SNOW":0.9}},"isVote":1,"tweetType":1,"viewCount":2284,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147921660,"gmtCreate":1626328801950,"gmtModify":1633927802368,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Norm is earnings out SP drops but not sure about TSM","listText":"Norm is earnings out SP drops but not sure about TSM","text":"Norm is earnings out SP drops but not sure about TSM","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147921660","repostId":"1113252389","repostType":4,"repost":{"id":"1113252389","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626327337,"share":"https://www.laohu8.com/m/news/1113252389?lang=zh_CN&edition=full","pubTime":"2021-07-15 13:35","market":"us","language":"en","title":"TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>芯片需求强劲台积电第二季度利润增长11%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1113252389","media":"Tiger Newspress","summary":"Taiwan Semiconductor Manufacturing Co. reported an 11% increase in quarterly profit, underscoring ho","content":"<p><a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor Manufacturing</a> Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.</p><p><blockquote><a href=\"https://laohu8.com/S/TSM\">台积电</a>Co.报告季度利润增长11%，突显出该公司如何从全球芯片短缺中受益，这推动了汽车和其他行业的订单增加。</blockquote></p><p> Net income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.</p><p><blockquote>截至6月份的季度净利润升至新台币1,344亿元（合48亿美元），略低于分析师平均预期的1,361.5亿元。根据之前发布的月度销售数据，收入为新台币3,721.5亿元。</blockquote></p><p> While an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.</p><p><blockquote>尽管持续的半导体短缺阻碍了全球经济从Covid-19中复苏，但全球最大的合同芯片制造商台积电等供应商在竞相履行订单时也是受益者之一。这家台湾公司也可能从计划中获得提振<a href=\"https://laohu8.com/S/AAPL\">苹果</a>其最大客户Inc.将在今年下半年准备9000万部升级版iPhone。</blockquote></p><p> “As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” <a href=\"https://laohu8.com/S/C\">Citigroup</a> analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”</p><p><blockquote>“由于台积电可能会在未来几个季度继续以极高的利用率装载其产能，我们预计强劲的收入势头将持续到2021年底，”<a href=\"https://laohu8.com/S/C\">花旗集团</a>分析师Roland Shu上周在一份报告中写道。“强劲的需求但供应链产能增加有限，将继续使台积电能够最好地利用其产能，并进一步加强其定价能力。”</blockquote></p><p> In early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.</p><p><blockquote>7月初，戴姆勒股份公司和捷豹路虎警告称，持续的芯片短缺将进一步削减销量，后者表示第二季度的交付量将比最初想象的差50%。英国5月份经济增长放缓至0.8%，部分原因是半导体短缺导致运输设备产量下降16.4%。</blockquote></p><p> <a href=\"https://laohu8.com/S/UMC\">United Microelectronics</a> Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.</p><p><blockquote><a href=\"https://laohu8.com/S/UMC\">联合微电子</a>台积电规模较小的竞争对手Corp.上周表示，芯片需求可能会继续超过供应，直到2023年。</blockquote></p><p> In response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.</p><p><blockquote>为了应对汽车制造商的需求，台积电表示将增加对该行业的出货量。来自汽车客户的收入较第一季度增长了12%，而高性能计算也以类似的幅度攀升。智能手机客户的销售额是其收入的最大部分，在季节性放缓的第二季度下降了3%。</blockquote></p><p> Gross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., <a href=\"https://laohu8.com/S/AONE\">one</a> of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.</p><p><blockquote>毛利率为50%，低于分析师预测的约51%的平均水平。6月初，台湾中部一家工厂发生聚集性Covid-19感染，迫使金源电子股份有限公司(King Yuan Electronics Co.,<a href=\"https://laohu8.com/S/AONE\">一</a>全球领先的芯片测试服务提供商之一，暂时关闭运营。这导致全球许多人所依赖的台湾半导体供应链出现轻微中断。台积电周一表示，其三名员工被确认感染，但没有看到对运营有任何影响。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8972f21d044da7c44c189d05e553355d\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul>  <li>TSMC today announced consolidated <b>revenue of &nbsp;NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit)</b> for the second quarter ended June 30, 2021.</li>  <li>Year-over-year, second quarter <b>revenue increased 19.8% while net income and diluted EPS both increased 11.2%.</b> Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</li>  <li>In US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.</li>  <li><b>Gross margin for the quarter was 50.0%,</b> operating margin was 39.1%, and net profit margin was 36.1%.</li>  <li>In the second quarter, <b>shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%.</b> <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.</li> </ul> <img src=\"https://static.tigerbbs.com/3f1042154c2034c25d54d740e91d9a2e\" tg-width=\"658\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>台积电今日宣布合并<b>营收3721.5亿元，净收入1343.6亿元，每股摊薄收益5.18元（每ADR单位0.93美元）</b>截至2021年6月30日的第二季度。</li><li>第二季度同比<b>收入增长19.8%，净利润和摊薄后每股收益均增长11.2%。</b>与2021年第一季度相比，第二季度业绩收入增长2.7%，净利润下降3.8%。所有数字均根据TIFRS按综合基准编制。</li><li>以美元计算，第二季度营收为132.9亿美元，同比增长28.0%，环比增长2.9%。</li><li><b>本季度毛利率为50.0%，</b>营业利润率39.1%，净利润率36.1%。</li><li>二季度，<b>5纳米出货量占晶圆总收入的18%；7纳米占31%。</b><a href=\"https://laohu8.com/S/AEIS\">先进的</a>技术，定义为7纳米及更先进的技术，占晶圆总收入的49%。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>芯片需求强劲台积电第二季度利润增长11%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>芯片需求强劲台积电第二季度利润增长11%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-15 13:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor Manufacturing</a> Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.</p><p><blockquote><a href=\"https://laohu8.com/S/TSM\">台积电</a>Co.报告季度利润增长11%，突显出该公司如何从全球芯片短缺中受益，这推动了汽车和其他行业的订单增加。</blockquote></p><p> Net income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.</p><p><blockquote>截至6月份的季度净利润升至新台币1,344亿元（合48亿美元），略低于分析师平均预期的1,361.5亿元。根据之前发布的月度销售数据，收入为新台币3,721.5亿元。</blockquote></p><p> While an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.</p><p><blockquote>尽管持续的半导体短缺阻碍了全球经济从Covid-19中复苏，但全球最大的合同芯片制造商台积电等供应商在竞相履行订单时也是受益者之一。这家台湾公司也可能从计划中获得提振<a href=\"https://laohu8.com/S/AAPL\">苹果</a>其最大客户Inc.将在今年下半年准备9000万部升级版iPhone。</blockquote></p><p> “As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” <a href=\"https://laohu8.com/S/C\">Citigroup</a> analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”</p><p><blockquote>“由于台积电可能会在未来几个季度继续以极高的利用率装载其产能，我们预计强劲的收入势头将持续到2021年底，”<a href=\"https://laohu8.com/S/C\">花旗集团</a>分析师Roland Shu上周在一份报告中写道。“强劲的需求但供应链产能增加有限，将继续使台积电能够最好地利用其产能，并进一步加强其定价能力。”</blockquote></p><p> In early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.</p><p><blockquote>7月初，戴姆勒股份公司和捷豹路虎警告称，持续的芯片短缺将进一步削减销量，后者表示第二季度的交付量将比最初想象的差50%。英国5月份经济增长放缓至0.8%，部分原因是半导体短缺导致运输设备产量下降16.4%。</blockquote></p><p> <a href=\"https://laohu8.com/S/UMC\">United Microelectronics</a> Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.</p><p><blockquote><a href=\"https://laohu8.com/S/UMC\">联合微电子</a>台积电规模较小的竞争对手Corp.上周表示，芯片需求可能会继续超过供应，直到2023年。</blockquote></p><p> In response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.</p><p><blockquote>为了应对汽车制造商的需求，台积电表示将增加对该行业的出货量。来自汽车客户的收入较第一季度增长了12%，而高性能计算也以类似的幅度攀升。智能手机客户的销售额是其收入的最大部分，在季节性放缓的第二季度下降了3%。</blockquote></p><p> Gross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., <a href=\"https://laohu8.com/S/AONE\">one</a> of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.</p><p><blockquote>毛利率为50%，低于分析师预测的约51%的平均水平。6月初，台湾中部一家工厂发生聚集性Covid-19感染，迫使金源电子股份有限公司(King Yuan Electronics Co.,<a href=\"https://laohu8.com/S/AONE\">一</a>全球领先的芯片测试服务提供商之一，暂时关闭运营。这导致全球许多人所依赖的台湾半导体供应链出现轻微中断。台积电周一表示，其三名员工被确认感染，但没有看到对运营有任何影响。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8972f21d044da7c44c189d05e553355d\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul>  <li>TSMC today announced consolidated <b>revenue of &nbsp;NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit)</b> for the second quarter ended June 30, 2021.</li>  <li>Year-over-year, second quarter <b>revenue increased 19.8% while net income and diluted EPS both increased 11.2%.</b> Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</li>  <li>In US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.</li>  <li><b>Gross margin for the quarter was 50.0%,</b> operating margin was 39.1%, and net profit margin was 36.1%.</li>  <li>In the second quarter, <b>shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%.</b> <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.</li> </ul> <img src=\"https://static.tigerbbs.com/3f1042154c2034c25d54d740e91d9a2e\" tg-width=\"658\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>台积电今日宣布合并<b>营收3721.5亿元，净收入1343.6亿元，每股摊薄收益5.18元（每ADR单位0.93美元）</b>截至2021年6月30日的第二季度。</li><li>第二季度同比<b>收入增长19.8%，净利润和摊薄后每股收益均增长11.2%。</b>与2021年第一季度相比，第二季度业绩收入增长2.7%，净利润下降3.8%。所有数字均根据TIFRS按综合基准编制。</li><li>以美元计算，第二季度营收为132.9亿美元，同比增长28.0%，环比增长2.9%。</li><li><b>本季度毛利率为50.0%，</b>营业利润率39.1%，净利润率36.1%。</li><li>二季度，<b>5纳米出货量占晶圆总收入的18%；7纳米占31%。</b><a href=\"https://laohu8.com/S/AEIS\">先进的</a>技术，定义为7纳米及更先进的技术，占晶圆总收入的49%。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113252389","content_text":"Taiwan Semiconductor Manufacturing Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.\nNet income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.\nWhile an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by Apple Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.\n“As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” Citigroup analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”\nIn early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.\nUnited Microelectronics Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.\nIn response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.\nGross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., one of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.\n\n\nTSMC today announced consolidated revenue of  NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit) for the second quarter ended June 30, 2021.\nYear-over-year, second quarter revenue increased 19.8% while net income and diluted EPS both increased 11.2%. Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.\nIn US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.\nGross margin for the quarter was 50.0%, operating margin was 39.1%, and net profit margin was 36.1%.\nIn the second quarter, shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%. Advanced technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.","news_type":1,"symbols_score_info":{"TSM":0.9}},"isVote":1,"tweetType":1,"viewCount":1164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154321641,"gmtCreate":1625482293784,"gmtModify":1633940318766,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Let them short","listText":"Let them short","text":"Let them short","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/154321641","repostId":"1199383023","repostType":4,"repost":{"id":"1199383023","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625234763,"share":"https://www.laohu8.com/m/news/1199383023?lang=zh_CN&edition=full","pubTime":"2021-07-02 22:06","market":"us","language":"en","title":"Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199383023","media":"Tiger Newspress","summary":"Iceberg Research, a short seller,said they're shorting AMC Entertainment.\nAMC stock tumbled 10% in F","content":"<p>Iceberg Research, a short seller,said&nbsp;they're shorting AMC Entertainment.</p><p><blockquote>卖空者Iceberg Research表示，他们正在做空AMC院线。</blockquote></p><p> AMC&nbsp;stock&nbsp;tumbled&nbsp;10%&nbsp;in Friday morning trading.</p><p><blockquote>AMC股价周五早盘下跌10%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fcd7b7275c61489d2f5ef4c91a74765\" tg-width=\"840\" tg-height=\"470\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-02 22:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Iceberg Research, a short seller,said&nbsp;they're shorting AMC Entertainment.</p><p><blockquote>卖空者Iceberg Research表示，他们正在做空AMC院线。</blockquote></p><p> AMC&nbsp;stock&nbsp;tumbled&nbsp;10%&nbsp;in Friday morning trading.</p><p><blockquote>AMC股价周五早盘下跌10%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fcd7b7275c61489d2f5ef4c91a74765\" tg-width=\"840\" tg-height=\"470\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199383023","content_text":"Iceberg Research, a short seller,said they're shorting AMC Entertainment.\nAMC stock tumbled 10% in Friday morning trading.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":1235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":691834800,"gmtCreate":1640163150399,"gmtModify":1640163150399,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/V03.SI\">$VENTURE CORPORATION LIMITED(V03.SI)$</a>just keep it for dividends, it is cash rich.","listText":"<a href=\"https://laohu8.com/S/V03.SI\">$VENTURE CORPORATION LIMITED(V03.SI)$</a>just keep it for dividends, it is cash rich.","text":"$VENTURE CORPORATION LIMITED(V03.SI)$just keep it for dividends, it is cash rich.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691834800","isVote":1,"tweetType":1,"viewCount":2761,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603247312,"gmtCreate":1638418786833,"gmtModify":1638419068422,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","listText":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","text":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603247312","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohu8.com/m/news/1119742422?lang=zh_CN&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna或辉瑞股票：随着奥密克戎蔓延，该买哪一只？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-01 22:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自发现奥密克戎变种以来，对大流行的担忧再次出现，疫苗相关股票重新成为人们关注的焦点。今天，我们仔细看看Moderna和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎重新引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&amp;P 500&nbsp;dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock&nbsp;was up a more modest 2.5%.</p><p><blockquote>11月26日星期五，奥密克戎新闻频道播出后，股市遭到抛售。由于不确定性，标普500下跌2%。Moderna股票是为数不多的上涨者之一，该股在周五交易时段上涨了20%，而辉瑞股票则小幅上涨了2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的COVID-19疫苗制造商之间，我们评估了Moderna和辉瑞的股票，并问自己：在奥密克戎恐惧挥之不去的情况下，哪一家更值得买入？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>Moderna股票目前有13名分析师一致持有，平均目标价为298美元，这表明较当前水平下跌17%。华尔街的评估表明，股价可能已经领先于基本面，因为自COVID-19大流行开始以来，MRNA已上涨超过1,200%。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who&nbsp;reiterated&nbsp;his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>关于Moderna股票的最新报告来自Piper Sandler的Edward Tenthoff，他重申了买入建议，并在奥密克戎新闻的支持下预测目标价为348美元。分析师认为，该公司已为新变种的出现做好了准备，并且“非常适合快速更换新版本的刺突抗原”以制造新的COVID-19疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison&nbsp;reiterated&nbsp;his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的Matthew Harrison一周前重申了对MRNA的中性评级，目标价为313美元。该分析师提到，Moderna年底前流感疫苗数据的公布可能会成为该股的积极催化剂。如果结果是积极的，市场可能会预计长期流感和新冠疫苗收入约为100亿美元，使股价上涨10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度买入，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，继11月上涨之后，估值可能会被拉低。根据13份报告，PFE给予适度买入建议，平均目标价为50美元。</blockquote></p><p> JPMorgan‘s Chris Schott&nbsp;raised&nbsp;the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的Chris Schott将辉瑞的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然分析师认为该公司核心业务的上涨空间有限，但他不会对近期股价上涨感到惊讶奥密克戎头条新闻。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is&nbsp;skeptical&nbsp;on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>PFE的最新更新来自瑞穗证券的Vamil Divan。他对辉瑞股票持怀疑态度，并认为下行风险为16%。但这位分析师表示，奥密克戎可能会增加近期对辉瑞COVID-19疫苗的需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街模因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>COVID-19疫苗制造商在短期内自然可能会从奥密克戎担忧中受益。例如，自2020年3月COVID-19大流行开始以来，Moderna的股价已上涨超过1,200%，而辉瑞股价同期上涨了79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE表现。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞比Moderna大得多，市值为3000亿美元，而Moderna为1330亿美元。两家公司都拥有强大的疫苗管道和技术，但Moderna可能会从当前的大流行中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为MRNA是COVID-19发展的更好短期赌注。然而，出于同样的原因，并且由于2023年市盈率高达32倍，该股可能会更加波动，并存在更高的下行风险。另一方面，PFE可能是整个医疗保健领域更好的长期押注，特别是考虑到2023年去风险市盈率仅为13倍。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":161871614,"gmtCreate":1623919953238,"gmtModify":1634025869982,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/161871614","repostId":"1147243421","repostType":4,"repost":{"id":"1147243421","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623918768,"share":"https://www.laohu8.com/m/news/1147243421?lang=zh_CN&edition=full","pubTime":"2021-06-17 16:32","market":"us","language":"en","title":"Vaccine sector stocks gained in pre-market trading.<blockquote>疫苗板块股票在盘前交易中上涨。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1147243421","media":"Tiger Newspress","summary":"Vaccine sector stocks gained in pre-market trading.\nNovavax,Moderna and BioNTech shares were up bewt","content":"<p>Vaccine&nbsp;sector&nbsp;stocks gained in pre-market&nbsp;trading.</p><p><blockquote>疫苗板块股票在盘前交易中上涨。</blockquote></p><p> Novavax,Moderna&nbsp;and&nbsp;BioNTech&nbsp;shares&nbsp;were&nbsp;up&nbsp;bewteen&nbsp;1%&nbsp;and&nbsp;5%.</p><p><blockquote>Novavax、Moderna和BioNTech股价上涨1%至5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bcf7ccd098da30e231e2f93a2600de4a\" tg-width=\"1291\" tg-height=\"641\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine sector stocks gained in pre-market trading.<blockquote>疫苗板块股票在盘前交易中上涨。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine sector stocks gained in pre-market trading.<blockquote>疫苗板块股票在盘前交易中上涨。</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-06-17 16:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vaccine&nbsp;sector&nbsp;stocks gained in pre-market&nbsp;trading.</p><p><blockquote>疫苗板块股票在盘前交易中上涨。</blockquote></p><p> Novavax,Moderna&nbsp;and&nbsp;BioNTech&nbsp;shares&nbsp;were&nbsp;up&nbsp;bewteen&nbsp;1%&nbsp;and&nbsp;5%.</p><p><blockquote>Novavax、Moderna和BioNTech股价上涨1%至5%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/bcf7ccd098da30e231e2f93a2600de4a\" tg-width=\"1291\" tg-height=\"641\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147243421","content_text":"Vaccine sector stocks gained in pre-market trading.\nNovavax,Moderna and BioNTech shares were up bewteen 1% and 5%.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}